It is a broadly described annual report of Dr. Reddy’s Laboratories Limited in the year of 2012-2013. During the financial year, revenues increased by 20% to Rs. 116,266 million that is $2.23* billion in FY2013 from Rs. 96,737 million in FY2012. EBITDA increased by 9.5% to Rs. 27,819 million in FY2013 from Rs. 25,409 million in FY2012. Net profit of Rs. 16,776 million in FY2013 from Rs. 14,262 million in FY2012, a growth of 18%. Fully diluted earnings per share increased to Rs. 98.4 in FY2013 from Rs. 83.8 in FY2012, a growth of 17%. The paid-up share capital of The Company increased by Rs. 1.38 million in FY2013.
The Board of Directors is pleased to recommend a dividend of Rs. 15/- on every equity share of R. 5/- each (@300%) for FY2013.
More Annual Report of Dr. Reddy’s Laboratories Limited:
- Annual Report 2001-2002 of Dr. Reddy’s Laboratories Limited
- Annual Report 2002-2003 of Dr. Reddy’s Laboratories Limited
- Annual Report 2003-2004 of Dr. Reddy’s Laboratories Limited
- Annual Report 2004-2005 of Dr. Reddy’s Laboratories Limited
- Annual Report 2005-2006 of Dr. Reddy’s Laboratories Limited
- Annual Report 2006-2007 of Dr. Reddy’s Laboratories Limited
- Annual Report 2007-2008 of Dr. Reddy’s Laboratories Limited
- Annual Report 2008-2009 of Dr. Reddy’s Laboratories Limited
- Annual Report 2009-2010 of Dr. Reddy’s Laboratories Limited
- Annual Report 2010-2011 of Dr. Reddy’s Laboratories Limited
- Annual Report 2011-2012 of Dr. Reddy’s Laboratories Limited
- Annual Report 2012-2013 of Dr. Reddy’s Laboratories Limited
- Annual Report 2013-2014 of Dr. Reddy’s Laboratories Limited
- Annual Report 2014-2015 of Dr. Reddy’s Laboratories Limited
- Annual Report 2015-2016 of Dr. Reddy’s Laboratories Limited
- Annual Report 2016-2017 of Dr. Reddy’s Laboratories Limited
